Annabelle Monnet
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials
Most-Cited Works
- → The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks(2007)673 cited
- → Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries(2005)595 cited
- → Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study(2015)580 cited
- → Trial of Prasinezumab in Early-Stage Parkinson’s Disease(2022)368 cited
- → Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease(2024)101 cited
- → MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia(2020)72 cited
- → Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆(2020)45 cited
- → Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial(2024)32 cited
- → Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials(2024)12 cited
- → MIRROS: An ongoing randomized phase 3 trial of idasanutlin + ARA-C in patients with relapsed or refractory acute myeloid leukemia.(2019)9 cited